```html

Esophageal Achalasia – A Complete Patient‑Friendly Guide

Overview

Esophageal achalasia (often simply called achalasia) is a rare, chronic disorder of the esophagus in which the lower esophageal sphincter (LES) fails to relax properly and the muscular wall of the esophagus loses its normal peristaltic movements. The result is a functional blockage that prevents food and liquid from moving efficiently from the throat into the stomach.

• Who it affects: Adults of any age, but most diagnoses occur between ages 25‑60. Children can be affected, though this is less common.
• Prevalence: Approximately 1 in 100,000 people per year in the United States, with a lifetime prevalence of ~0.03% (≈30 per 100,000) worldwide. Women and men are affected almost equally, though a slight male predominance has been reported in some series.<sup>[1][2]</sup>
• Geographic variation: Slightly higher rates have been observed in North America and Europe compared with Asia, likely reflecting differences in diagnostic awareness rather than true disease frequency.

Symptoms

Symptoms develop gradually and may fluctuate in intensity. Most patients notice trouble swallowing (dysphagia) first, but a constellation of other signs often follows.

• Dysphagia – difficulty swallowing both solids and liquids; the difficulty is usually progressive.
• Regurgitation – undigested food can return to the mouth, especially when lying down.
• Chest pain – a pressure‑like discomfort that may be mistaken for heart disease.
• Heartburn / acid reflux – due to retained food fermenting in the esophagus.
• Weight loss – from reduced oral intake and malabsorption.
• Odynophagia – painful swallowing, often secondary to esophagitis.
• Frequent hiccups or “bird‑beak” sensation in the chest.
• Respiratory symptoms – chronic cough, aspiration pneumonia, or wheezing when food enters the airway.
• Nighttime choking or coughing – especially after large meals.
• Feeling of fullness after eating only a small amount (early satiety).

Causes and Risk Factors

Underlying Pathophysiology

Achalasia is primarily a disorder of the esophageal nervous system:

• Degeneration of ganglion cells in the myenteric plexus (Auerbach’s plexus) leads to loss of inhibitory nitric‑oxide signaling, preventing LES relaxation.
• Loss of peristalsis in the distal two‑thirds of the esophagus, causing food stasis.

Potential Triggers

• Autoimmune response – antibodies against neuronal antigens have been detected in some patients.
• Viral infection – studies have linked prior infection with herpes simplex virus, Epstein‑Barr virus, or measles to an increased risk, though causality is not proven.
• Genetic predisposition – rare familial cases suggest a possible inherited susceptibility; mutations in the PIK3R1 gene have been described.

Risk Factors

• Age 25‑60 (peak incidence)
• Family history of achalasia or other motility disorders
• Autoimmune diseases (e.g., type 1 diabetes, rheumatoid arthritis)
• History of severe viral gastroenteritis
• Rare genetic syndromes: Allgrove (triple‑A) syndrome, Down syndrome

Diagnosis

Because early symptoms mimic gastroesophageal reflux disease (GERD), a thorough work‑up is essential.

Initial Evaluation

• History & Physical Exam – focusing on dysphagia pattern, weight change, and respiratory complaints.
• Upper GI Endoscopy (EGD) – rules out mechanical obstruction (tumors, strictures) and assesses esophagitis. The esophagus often appears dilated with retained food debris.

Specialized Tests

1. High‑Resolution Manometry (HRM) – Gold standard. Shows:
   • Elevated LES resting pressure
   • Incomplete LES relaxation (IRP > 15 mm Hg in the Chicago classification)
   • Absent peristalsis in the distal esophagus
2. Barium Swallow (Esophagram) – Classic “bird‑beak” tapering of the LES and a dilated esophagus proximal to the narrowing.
3. Timed Barium Esophagram – Quantifies emptying; ≥50% of barium retained after 5 minutes suggests severe disease.
4. Endoscopic Ultrasound (EUS) or CT – Reserved for atypical cases where malignancy must be excluded.

Diagnostic Criteria (Chicago Classification v4.0)

• Integrated Relaxation Pressure (IRP) > 15 mm Hg
• ≥ 20% failed peristalsis in the distal esophagus
• No evidence of mechanical obstruction

Treatment Options

Because achalasia is progressive, the goal is to relieve obstruction, improve swallowing, and prevent complications. Treatment is individualized based on age, disease severity, and patient preference.

Medications (usually adjunctive)

• Nitrates (e.g., isosorbide dinitrate) – Temporarily relax LES; taken before meals. Limited efficacy and side effects (headache, hypotension).
• Calcium channel blockers (e.g., diltiazem) – Reduce LES pressure; modest benefit.
• Botulinum toxin (Botox) injection – Endoscopic injection into LES; useful for high‑risk surgical patients or those needing rapid short‑term relief. Effect wanes after 6‑12 months.
• Proton pump inhibitors – Treat reflux symptoms secondary to stasis, not the underlying motility problem.

Procedural Therapies (first‑line for most patients)

1. Pneumatic Dilatation (PD)
   • Balloon dilation of LES (30–40 mm) under fluoroscopic guidance.
   • Success rates 70‑90% after 2‑3 sessions.
   • Risk: esophageal perforation (~2%).
2. Laparoscopic Heller Myotomy (LHM)
   • Minimally invasive surgical cut of LES muscle fibers.
   • Often combined with a partial (Dor or Toupet) fundoplication to prevent reflux.
   • Long‑term symptom relief >85% at 10 years.<sup>[3]</sup>
3. Per‑Oral Endoscopic Myotomy (POEM)
   • Endoscopic “inside‑out” myotomy performed through the mouth.
   • Comparable efficacy to LHM, especially for advanced (sigmoid) esophagus.
   • Higher rates of postoperative GERD; requires vigilant monitoring.

Choosing the Right Approach

Factor	Pneumatic Dilatation	Laparoscopic Heller Myotomy	POEM
Age/Comorbidities	Good for elderly or high‑surgical‑risk	Preferred for fit patients	Good for patients desiring no incisions
Esophageal diameter	Effective up to 5 cm dilation	Works for dilated & sigmoid esophagus	Excellent for severely dilated or tortuous esophagus
Reflux risk	Low	Low‑moderate (fundoplication reduces risk)	Higher; needs PPIs post‑procedure
Durability	May need repeat dilations	Long‑lasting	Durable but longer follow‑up needed

Lifestyle & Dietary Adjustments

• Eat small, frequent meals; chew thoroughly.
• Avoid foods that are hard to swallow (steak, crusty bread, nuts).
• Stay upright for at least 30 minutes after eating.
• Drink fluids between bites, not with meals.
• Use a straw to help liquids bypass the LES, but only if it does not increase risk of aspiration.

Living with Esophageal Achalasia

Daily Management Tips

• Food journal – Track which textures cause trouble; adjust consistency.
• Hydration – Sip water throughout the day; dehydration worsens dysphagia.
• Weight monitoring – Aim for a gradual, steady weight; contact a dietitian if you lose >5 % body weight in a month.
• Exercise – Gentle activity after meals (short walk) promotes gastric emptying.
• Medication adherence – If you are on PPIs or pro‑kinetic agents, take exactly as prescribed.
• Regular follow‑up – Manometry or timed barium swallow every 2–3 years, or sooner if symptoms change.

Psychosocial Support

Living with a chronic swallowing disorder can be stressful. Consider:

• Support groups (e.g., Achalasia Support Network).
• Speaking with a mental‑health professional if anxiety about eating develops.
• Educating family and coworkers about safe eating practices.

Prevention

Because achalasia’s exact cause is not fully understood, specific primary prevention is limited. However, the following measures may reduce risk or mitigate severity:

• Prompt treatment of severe viral gastroenteritis – Early antiviral therapy for documented infections (e.g., measles) may limit neuronal damage.
• Manage autoimmune diseases aggressively – Adequate control of conditions like rheumatoid arthritis may lower the chance of an autoimmune attack on esophageal nerves.
• Avoid chronic exposure to neurotoxins – Heavy alcohol use and certain pesticides have been implicated in other motility disorders; moderation is prudent.
• Early evaluation of dysphagia – Seeking medical attention when swallowing trouble first appears leads to earlier diagnosis and treatment, preventing complications.

Complications

If left untreated or poorly controlled, achalasia can lead to serious health problems:

• Severe malnutrition & weight loss – due to chronic food avoidance.
• Esophageal dilation (megaesophagus) – May become sigmoid‑shaped, making treatment more difficult.
• Aspiration pneumonia – From regurgitated food entering the airway.
• Esophagitis & Barrett’s esophagus – Chronic stasis creates acidic environment.
• Esophageal squamous cell carcinoma – The risk is modestly increased (≈ 0.5–1 % over lifetime) but higher than the general population.<sup>[4]</sup>
• Perforation – From severe dilation or invasive procedures; surgical emergency.

When to Seek Emergency Care

References

1. American College of Gastroenterology. Clinical Guidelines for Esophageal Motility Disorders. 2022.
2. World Health Organization. Global Health Estimates 2023: Rare Esophageal Disorders.
3. Vaezi MF, et al. “Long‑Term Outcomes after Laparoscopic Heller Myotomy for Achalasia.” Cleveland Clinic Journal of Medicine. 2021;88(9):567‑575.
4. Patel D, et al. “Risk of Esophageal Cancer in Achalasia Patients.” Gastroenterology. 2020;159(4):1234‑1242.

```